
Oxxyl Pharma Private Limited
About Oxxyl Pharma Private Limited
Data last updated:
Oxxyl Pharma Private Limited is a private limited company based in Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 January 2025.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2025PTC440938.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajesh Shrivastava and Manoj Mishra.
Its last annual general meeting (AGM) was held on 25 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 567B GF Blk – D Astha Vihar, Prem Nagar – 3, Delhi, India – 110086.
As per the financials filed for FY 2026, the company reported a revenue of ₹70,803. For the same year it recorded a net loss of ₹46,466 (net margin -65.6%) and EBITDA of -₹46,466 (EBITDA margin -65.6%).
Company details
Contact details
Oxxyl Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered Address567B GF Blk – D Astha Vihar, Prem Nagar – 3, Delhi, India – 110086
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxxyl Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Oxxyl Pharma Private Limited, buy the company report.
Financials of Oxxyl Pharma Private Limited
FY 2026 filings availableOxxyl Pharma Private Limited reported revenue of ₹70,803 for FY 2026.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹70,803 | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹46,466 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹46,466 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -65.6% | |
| Net Profit Margin | -65.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Oxxyl Pharma Private Limited, buy the company report.
Board of directors of Oxxyl Pharma Private Limited
Oxxyl Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajesh Shrivastava | Director | 09 Jan 2025 | 1 Years 10 Months | Current |
| Manoj Mishra | Director | 09 Jan 2025 | 1 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Oxxyl Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxxyl Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Oxxyl Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Oxxyl Pharma Private Limited has 2 board changes on record since 2025: 2 appointments. The latest: Ajesh Shrivastava was appointed as Director on 09 Jan 2025.
Frequently asked questions
Oxxyl Pharma is an active private limited company based in Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 January 2025 (1 year old) and is registered under CIN U21001DL2025PTC440938.
Oxxyl Pharma has 2 current directors:
- Ajesh Shrivastava - Director
- Manoj Mishra - Director
The latest financial statements of Oxxyl Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 May 2026. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Oxxyl Pharma is U21001DL2025PTC440938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxxyl Pharma was incorporated on 09 January 2025, making it 1 year old. It is registered with the Registrar of Companies, Delhi.
Ajesh Shrivastava was appointed as Director on 09 Jan 2025. Manoj Mishra was appointed as Director on 09 Jan 2025.
The registered office of Oxxyl Pharma is at 567B GF Blk – D Astha Vihar, Prem Nagar – 3, Delhi, India – 110086.
Oxxyl Pharma operates in the paper industry, in the paper and paper products segment.
Oxxyl Pharma can be reached at its registered office: 567B GF Blk – D Astha Vihar, Prem Nagar – 3, Delhi, India – 110086.
Oxxyl Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

